heparin
美 ['hepərɪn]英 ['hepərɪn]
- n.【药】肝素
- 网络肝磷脂；肝素钠；抗凝剂
heparinheparin
肝素
...BEX, 加拿大蒙特利尔公司生产）是一种特异作用于肝素（heparin）和类肝素分子的多糖列解酶。
肝磷脂
钠肝磷脂(heparin)能放松皮肤组织结构，具消炎作用，及能帮助疤痕组织锁紧水份 尿囊素 (allantoin)能促进伤口愈合。
肝素钠
肝素钠 （HEPARIN） 透明质酸 熊果苷 云母粉 陈伟 先生 电话：86-13925020737 传真：N/A 地址：广州市天河区粤肯路 亚硝 …
抗凝剂
抗凝剂 ( Heparin )、10 ml 空针 1支、20 ml N/S 1瓶、2x2纱布 1包、3M 纸胶 适量。【扎针】1. 洗手，铺设无菌面，以无菌手 …
抗凝血剂
使用抗凝血剂(Heparin)后可能演变成颅内出血周边动脉疾病病史 ECMO设置困难，且多肢体并发症 长期存活机会低 一、前言 …
抗凝血剂肝素钠
...者，在使用美国百特医疗公司(下称“美国百特”)所产抗凝血剂肝素钠(Heparin)后死亡，另有300多人出现了过敏反应和其他副 …
肝制凝素
4. 制造肝制凝素 ( heparin ).脂肪的代谢:综合三甘油脂,磷脂,胆固醇,而后与蛋白质结合成为脂蛋白质送出肝脏,在血液中运输或送 …
1
Geopolitics, public health and global business all bubbled up in dueling press conferences over the heparin imbroglio today.
今天在新闻发布会上相对于地缘政治、公共健康和全球商业问题，肝素纠葛是热点。
2
The congressmen said the FDA should have explored more thoroughly a possible broader role by the company in heparin contamination.
上述国会议员说，FDA本应该更加彻底地调查这家企业在肝素污染问题中可能扮演的更重大的角色。
3
We aimed to compare the efficacy and safety of enoxaparin with that of unfractionated heparin for patients with stroke.
我们的目的是比较卒中患者应用依诺肝素和普通肝素的有效性和安全性。
4
The company claims to be the world's biggest supplier of heparin products; its clients include leading global pharmaceutical companies.
公司声称是世界上最大的肝素钠供应商，客户包括全球范围内主要的制药企业。
5
In addition, the growth of cells was found to be affected by the surface density of immobilized heparin.
此外，细胞的生长被认为是受影响的面密度固定肝素。
6
Methods: Low molecular heparin sodium anticoagulation was used to carry out hemodialysis .
方法：应用吉派林（低分子肝素钠）作为抗凝剂进行血液透析。
7
Her clinical status remained stable and unimproved during the several hours between the administration of heparin and bronchoscopy.
在给予肝素之后、支气管镜检查之前的数小时中，她的临床状况保持稳定，但也没有改善。
8
It was proved that endothelial cells could grow on the surface of Ti-0 film which immobilized with albumin and heparin.
对钛氧膜表面直接吸附固定白蛋白，表明能够提高其血液相容性。
9
A thigh tourniquet, prophylactic intravenous antibiotics, and low-molecular-weight heparin anticoagulation were used in all patients.
所有的病人在大腿上应用止血带、预防性应用抗生素、低分子肝素抗凝。
10
Conclusion: Low molecular weight heparin can reduce the incidence of DVT after hip or knee replacements with a low incidence of side effect.
结论：预防性使用低分子肝素可以降低髋、膝关节置换术后DVT的发生，不良反应发生率低。
11
The result of collagen staining showed that heparin significantly inhibited fibrosis in rats.
网织纤维染色显示，肝素可明显抑制纤维增生。
12
Rather, the phasing out of heparin has followed a linear course over several years, with less variation between hospitals.
实际上，肝素的应用情况在最近数年中表现为一个线性降低的过程，且不同医院间差异不大。
13
Heparin, a commonly used anticoagulant agent, is frequently used in patients undergoing hemodialysis .
肝素（一种常使用的抗凝血剂）经常用在须要洗肾的病人身上。
14
Conclusion Heparin and its derivatives can be a novel therapy of asthma.
结论肝素及其衍生物有望成为新型治疗哮喘的药物。
15
Heparin has a larger volume of distribution and a more rapid plasma clearance in infants than in adults.
肝素有一个较大的体积和分布在婴儿比翻译公司更快速血浆间隙。
16
On the issue of the tainted heparin , Leavitt said both U. S. and Chinese scientists agree that the questionable samples were contaminated .
关于肝素污染问题，莱维特说，美国和中国科学家一致认为，有问题的样本受到了污染。
17
Unless contraindicated, patients also received 1000 units of intravenous heparin at the time of hip dislocation.
除非禁忌，患者在髋关节脱位时也要静注1000单位的肝素钠。
18
OBJECTIVE The aim of current study was to prepare and characterize novel iron heparin nanoparticles.
目的制备一种新型具有抗凝血活性的肝素铁纳米粒。
19
The most likely route of transmission was intravenous heparin flushes administered with a common syringe.
最可能的传播途径是使用同一付注射器给予静脉内肝素冲管。
20
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin(LMWH).
目的测定低分子肝素的分子量及其分布。
21
Conclusion Intra-arterial administration of heparin in hemodialysis significantly reduces the dosage of heparin with satisfactory safety.
结论动脉组肝素给药途径能够显著减少肝素使用量，临床应用安全性良好。
22
Conclusions: Combined therapy of compound glycyrrhizin tablet and heparin ointment is of low re occurrence rate. It is effective and safe.
结论：复方甘草酸甙片联合肝素软膏治疗湿疹疗效高，复发率低，安全性好。
23
Conclusion: This HPAEC method could be used to determine the content of free and linked sulfate of heparin-like materials.
结论：本文实验方法可以用于肝素类样品游离和结合硫酸根的测定。
24
Conclusion Low-molecular-weight heparin therapy was a safe and effective method to treat acute ischemic stroke.
结论低分子肝素治疗进展型缺血性脑卒中是比较安全、有效的方法。
25
He awaits the results of a randomized, placebo-controlled clinical trial of enoxaparin versus unfractionated heparin.
他还会继续等待针对依诺肝素和未分解肝素作用的具有随机安慰剂对照的临床研究的结果。
26
Connective tissues, joint fluid, and cartilage contain two-component polysaccharides, including heparin.
连接组织、连接流质和软骨中便含有二元多醣，包括肝素。
27
Conclusion: Low molecular heparin sodium anticoagulation during hemodialysis was simple, safe, and effective for high risk bleeding.
结论：吉派林在高危出血患者血液透析中使用方便，安全，效果良好。
28
The main treatment was low molecular weight heparin anticoagulation and low molecular weight dextran expansion.
低分子肝素抗凝、低分子右旋糖苷扩容为其主要的治疗手段。
29
a non-anticoagulant heparin is now in Phase I clinical trial for the prevention and treatment of protracted labour [52].
非肝素抗凝血剂是目前在第一阶段的预防和治疗的临床试验的长期劳动[52]。
30
The patient was begun on intravenous heparin, and his neurologic status remained stable with mild improvement in aphasia.
治疗首先静脉滴注肝磷脂，患者的神经系统症状稳定，失语有轻微好转。